Shortage outlook · all drugs · read October 2026
How long has Mixed amphetamine salts (Adderall generics) been on the FDA shortage list?
Mixed amphetamine salts (Adderall generics) has been on the FDA shortage list for 4 years. 79 of the 397 listings measured since 2014 lasted at least that long. Of the 79 past listings that reached the same age, 85% were still listed 6 months later (63 listings measured), 77% were still listed 12 months later (52 listings measured) and 55% were still listed 24 months later (33 listings measured). These are counts of listings, not a forecast.
Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.
Mixed amphetamine salts (Adderall generics) has been on the FDA shortage list for 4 years (November 2022 to October 2026).
- 79 of the 397 listings measured since 2014 lasted at least that long.
- Of the 79 past listings that reached the same age, 85% were still listed 6 months later (63 listings measured), 77% were still listed 12 months later (52 listings measured) and 55% were still listed 24 months later (33 listings measured).
- Mixed amphetamine salts (Adderall generics) has been listed 2 times since 2014: earlier listings lasted 2 years and 8 months.
- None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.
The listing history, to scale
- Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine...Listed October 2019 to May 2022 · 2 years and 8 months
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate...Listed since November 2022 · 4 years
What past listings of this age did
Of past listings that had already run 4 years, how many were still listed later?
What the FDA list says about it today
Reasons companies gave: shortage of an active ingredient (24), other (6) and demand increase for the drug (3); 40 of 73 gave none. FDA category: Psychiatry.
Company by company
Of 73 presentations, the companies reported 40 available, 14 with limited availability and 19 unavailable. This is each company's own report to the FDA, with the date of its last update.
- Granules Pharmaceuticals Inc.7 presentations · last updated 28 October 2026
- Aurobindo Pharma USA6 presentations · last updated 4 November 2026
- Oryza Pharmaceuticals Inc.5 presentations · last updated 15 October 2026
- Teva Pharmaceuticals USA, Inc.14 presentations · last updated 2 November 2026
- Elite Laboratories, Inc.7 presentations · last updated 3 November 2026
- Lannett Company, Inc.7 presentations · last updated 2 November 2026
- Sunrise Pharmaceutical, Inc.7 presentations · last updated 1 November 2026
- SpecGx LLC6 presentations · last updated 20 August 2026
- Alvogen5 presentations · last updated 2 November 2026
- Epic Pharma, LLC5 presentations · last updated 3 November 2026
- Sandoz Inc.4 presentations · last updated 9 November 2026
What DEA sets for it each year
DEA aggregate production quota, the two amphetamine quotas that feed mixed salts
D,L-amphetamine
- 202121,200 kg
- 202221,200 kg
- 202321,200 kg
- 202421,200 kg
- 202521,200 kg
- 2026established24,234 kg
- 2026adjusted 10 Nov31,655 kg
D-amphetamine (for sale)
- 202121,200 kg
- 202221,200 kg
- 202321,200 kg
- 202421,200 kg
- 202526,450 kg
- 2026established26,450 kg
- 2026adjusted 10 Nov37,108 kg
Kilograms of anhydrous acid or base, from the DEA table dated 13 March 2026 and, for the 2026 adjustment, Federal Register order 2026-22842 (signed 4 November, effective 10 November 2026). A quota is a yearly national ceiling on manufacturing; it is not a measure of stock.
FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026); DEA quota table dated 13 March 2026 and the Federal Register order of 10 November 2026. Listing is the FDA's status, not a statement about any pharmacy.
Where can you go from this result?
This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured. The stimulants page sets the DEA quota beside this history.
- Etomidate48 months
- Flurazepam Hydrochloride50 months
- Quinapril Hydrochloride45 months
- Quinapril/Hydrochlorothiazide45 months
To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.